Home - Products - Others - Other Targets - Tectorigenin 7-?O-?Xylosyl Glucoside

Tectorigenin 7-?O-?Xylosyl Glucoside

CAS No. 231288-19-0

Tectorigenin 7-?O-?Xylosyl Glucoside( Tectorigenin 7-O-xylosylglucoside )

Catalog No. M29234 CAS No. 231288-19-0

Tectorigenin 7-O-xylosylglucoside is a natural product.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 372 In Stock
5MG 244 In Stock
10MG 361 In Stock
25MG 606 In Stock
50MG 828 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tectorigenin 7-?O-?Xylosyl Glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Tectorigenin 7-O-xylosylglucoside is a natural product.
  • Description
    Tectorigenin 7-O-xylosylglucoside is a natural product.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Tectorigenin 7-O-xylosylglucoside
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    231288-19-0
  • Formula Weight
    594.522
  • Molecular Formula
    C27H30O15
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1c(O[C@@H]2O[C@H](CO[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • N-Formyl-Met-Leu-Phe...

    N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively.

  • Tetradecyl Acrylate

    Tetradecyl Acrylate (tetradecyl prop-2-enoate) can be used as a plastic additive and is commonly used in industry.

  • γ-2-MSH (41-58), ami...

    Melanocortin (MC) 3-MSH (Melanocyte-Stimulating Hormone) is believed to signal through the MC 3 receptor. It induces a sustained increase in intracellular free calcium levels ([Ca2+]i) in a subpopulation of pituitary cells. Most of the cells responding to 3-MSH express more than one pituitary hormone mRNA. The effect of 3-MSH is blocked by SHU9119, a MC3R and MC4R antagonist, in only 50% of the responsive cells, suggesting that in half of these cells the mediating receptor is not the MC3R. Low picomolar doses of 3-MSH increase [Ca2+]i in the growth hormone (GH)- and prolactin (PRL)-secreting GH3 cell line.